Hepatitis C Virus in Sub-Saharan Africa

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations

Abstract

Hepatitis C virus (HCV) is a major cause of chronic liver disease worldwide affecting 3% of the world population, which exceeds 180. million individuals. Sub-Saharan Africa is a region with significantly high prevalence of HCV with rates of approximately 5.3%. The central African region has the highest estimated prevalence of 6%, west Africa has an estimated prevalence of 2.4%, and southern and east Africa have the lowest estimated prevalence of 1.6%. Iatrogenic HCV transmission, sexual transmission, and intravenous drug use are among the modes of HCV transmission in Sub-Saharan Africa. The coexistence of HIV and some parasitic infections intensify the impact of HCV in these regions.

Original languageEnglish
Title of host publicationHepatitis C in Developing Countries
Subtitle of host publicationCurrent and Future Challenges
PublisherElsevier Inc.
Pages71-81
Number of pages11
ISBN (Electronic)9780128032343
ISBN (Print)9780128032336
DOIs
StatePublished - 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 5 - Gender Equality
    SDG 5 Gender Equality

Keywords

  • Africa
  • Coinfections
  • Disease burden
  • Hepatitis C
  • Prevalence
  • Prevention

Fingerprint

Dive into the research topics of 'Hepatitis C Virus in Sub-Saharan Africa'. Together they form a unique fingerprint.

Cite this